APO Research, Inc.

APO RESEARCH · REPORT

Bovine Blood Products

Selected research

Market Structure

Global Bovine Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Bovine Blood Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bovine Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bovine Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bovine Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bovine Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bovine Blood Products include Animal Technologies, Bio Nutrientes Brasil, Biological Industries, Biowest, Bovogen, Cytiva, ExCell Bio, Gemini and Internegocios, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bovine Blood Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bovine Blood Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bovine Blood Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bovine Blood Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Bovine Blood Products Segment by Company

Animal Technologies

Bio Nutrientes Brasil

Biological Industries

Biowest

Bovogen

Cytiva

ExCell Bio

Gemini

Internegocios

Moregate BioTech

NorthBio

PAN-Biotech

Peak Serum

R&D Systems

RMBIO

Serana

Seroxlab

Tissue Culture Biologicals

VWR

WISENT

Corning

Lanzhou Minhai

Merck

Jin Yuan Kang

Thermo Fisher

Zhejiang Tianhang Biotechnology

Bovine Blood Products Segment by Type

Bovine / Cow

Fetal Bovine

Others

Bovine Blood Products Segment by Application

Scientific Research

Industrial Production

Bovine Blood Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bovine Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bovine Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bovine Blood Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bovine Blood Products market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bovine Blood Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bovine Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bovine Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bovine Blood Products Industry Trends Table 2. Bovine Blood Products Industry Drivers Table 3. Bovine Blood Products Industry Opportunities and Challenges Table 4. Bovine Blood Products Industry Restraints Table 5. Global Bovine Blood Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bovine Blood Products Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bovine Blood Products Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Bovine Blood Products Sales Market Share by Manufacturers Table 9. Global Bovine Blood Products Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Bovine Blood Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bovine Blood Products Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bovine Blood Products Manufacturers, Product Type & Application Table 13. Global Bovine Blood Products Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bovine Blood Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Bovine / Cow Table 17. Major Manufacturers of Fetal Bovine Table 18. Major Manufacturers of Others Table 19. Global Bovine Blood Products Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Bovine Blood Products Sales by Type (2021-2026) & (K Units) Table 21. Global Bovine Blood Products Sales by Type (2027-2032) & (K Units) Table 22. Global Bovine Blood Products Sales Market Share by Type (2021-2026) Table 23. Global Bovine Blood Products Sales Market Share by Type (2027-2032) Table 24. Global Bovine Blood Products Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Bovine Blood Products Revenue by Type (2021-2026) & (K Units) Table 26. Global Bovine Blood Products Revenue by Type (2027-2032) & (K Units) Table 27. Global Bovine Blood Products Revenue Market Share by Type (2021-2026) Table 28. Global Bovine Blood Products Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Scientific Research Table 30. Major Manufacturers of Industrial Production Table 31. Global Bovine Blood Products Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Bovine Blood Products Sales by Application (2021-2026) & (K Units) Table 33. Global Bovine Blood Products Sales by Application (2027-2032) & (K Units) Table 34. Global Bovine Blood Products Sales Market Share by Application (2021-2026) Table 35. Global Bovine Blood Products Sales Market Share by Application (2027-2032) Table 36. Global Bovine Blood Products Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Bovine Blood Products Revenue by Application (2021-2026) & (K Units) Table 38. Global Bovine Blood Products Revenue by Application (2027-2032) & (K Units) Table 39. Global Bovine Blood Products Revenue Market Share by Application (2021-2026) Table 40. Global Bovine Blood Products Revenue Market Share by Application (2027-2032) Table 41. Global Bovine Blood Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Bovine Blood Products Sales by Region (2021-2026) & (K Units) Table 43. Global Bovine Blood Products Sales Market Share by Region (2021-2026) Table 44. Global Bovine Blood Products Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Bovine Blood Products Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Bovine Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Bovine Blood Products Sales by Country (2021-2026) & (K Units) Table 48. North America Bovine Blood Products Sales by Country (2027-2032) & (K Units) Table 49. Europe Bovine Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Bovine Blood Products Sales by Country (2021-2026) & (K Units) Table 51. Europe Bovine Blood Products Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Bovine Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Bovine Blood Products Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Bovine Blood Products Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Bovine Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Bovine Blood Products Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Bovine Blood Products Sales by Country (2027-2032) & (K Units) Table 58. Global Bovine Blood Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Bovine Blood Products Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Bovine Blood Products Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Bovine Blood Products Revenue Market Share by Region (2021-2026) Table 62. Global Bovine Blood Products Revenue Market Share by Region (2027-2032) Table 63. Animal Technologies Company Information Table 64. Animal Technologies Business Overview Table 65. Animal Technologies Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Animal Technologies Bovine Blood Products Product Portfolio Table 67. Animal Technologies Recent Development Table 68. Bio Nutrientes Brasil Company Information Table 69. Bio Nutrientes Brasil Business Overview Table 70. Bio Nutrientes Brasil Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Bio Nutrientes Brasil Bovine Blood Products Product Portfolio Table 72. Bio Nutrientes Brasil Recent Development Table 73. Biological Industries Company Information Table 74. Biological Industries Business Overview Table 75. Biological Industries Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Biological Industries Bovine Blood Products Product Portfolio Table 77. Biological Industries Recent Development Table 78. Biowest Company Information Table 79. Biowest Business Overview Table 80. Biowest Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Biowest Bovine Blood Products Product Portfolio Table 82. Biowest Recent Development Table 83. Bovogen Company Information Table 84. Bovogen Business Overview Table 85. Bovogen Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Bovogen Bovine Blood Products Product Portfolio Table 87. Bovogen Recent Development Table 88. Cytiva Company Information Table 89. Cytiva Business Overview Table 90. Cytiva Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Cytiva Bovine Blood Products Product Portfolio Table 92. Cytiva Recent Development Table 93. ExCell Bio Company Information Table 94. ExCell Bio Business Overview Table 95. ExCell Bio Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. ExCell Bio Bovine Blood Products Product Portfolio Table 97. ExCell Bio Recent Development Table 98. Gemini Company Information Table 99. Gemini Business Overview Table 100. Gemini Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Gemini Bovine Blood Products Product Portfolio Table 102. Gemini Recent Development Table 103. Internegocios Company Information Table 104. Internegocios Business Overview Table 105. Internegocios Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Internegocios Bovine Blood Products Product Portfolio Table 107. Internegocios Recent Development Table 108. Moregate BioTech Company Information Table 109. Moregate BioTech Business Overview Table 110. Moregate BioTech Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Moregate BioTech Bovine Blood Products Product Portfolio Table 112. Moregate BioTech Recent Development Table 113. NorthBio Company Information Table 114. NorthBio Business Overview Table 115. NorthBio Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. NorthBio Bovine Blood Products Product Portfolio Table 117. NorthBio Recent Development Table 118. PAN-Biotech Company Information Table 119. PAN-Biotech Business Overview Table 120. PAN-Biotech Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. PAN-Biotech Bovine Blood Products Product Portfolio Table 122. PAN-Biotech Recent Development Table 123. Peak Serum Company Information Table 124. Peak Serum Business Overview Table 125. Peak Serum Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Peak Serum Bovine Blood Products Product Portfolio Table 127. Peak Serum Recent Development Table 128. R&D Systems Company Information Table 129. R&D Systems Business Overview Table 130. R&D Systems Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. R&D Systems Bovine Blood Products Product Portfolio Table 132. R&D Systems Recent Development Table 133. RMBIO Company Information Table 134. RMBIO Business Overview Table 135. RMBIO Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. RMBIO Bovine Blood Products Product Portfolio Table 137. RMBIO Recent Development Table 138. Serana Company Information Table 139. Serana Business Overview Table 140. Serana Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Serana Bovine Blood Products Product Portfolio Table 142. Serana Recent Development Table 143. Seroxlab Company Information Table 144. Seroxlab Business Overview Table 145. Seroxlab Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Seroxlab Bovine Blood Products Product Portfolio Table 147. Seroxlab Recent Development Table 148. Tissue Culture Biologicals Company Information Table 149. Tissue Culture Biologicals Business Overview Table 150. Tissue Culture Biologicals Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Tissue Culture Biologicals Bovine Blood Products Product Portfolio Table 152. Tissue Culture Biologicals Recent Development Table 153. VWR Company Information Table 154. VWR Business Overview Table 155. VWR Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. VWR Bovine Blood Products Product Portfolio Table 157. VWR Recent Development Table 158. WISENT Company Information Table 159. WISENT Business Overview Table 160. WISENT Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. WISENT Bovine Blood Products Product Portfolio Table 162. WISENT Recent Development Table 163. Corning Company Information Table 164. Corning Business Overview Table 165. Corning Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Corning Bovine Blood Products Product Portfolio Table 167. Corning Recent Development Table 168. Lanzhou Minhai Company Information Table 169. Lanzhou Minhai Business Overview Table 170. Lanzhou Minhai Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Lanzhou Minhai Bovine Blood Products Product Portfolio Table 172. Lanzhou Minhai Recent Development Table 173. Merck Company Information Table 174. Merck Business Overview Table 175. Merck Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. Merck Bovine Blood Products Product Portfolio Table 177. Merck Recent Development Table 178. Jin Yuan Kang Company Information Table 179. Jin Yuan Kang Business Overview Table 180. Jin Yuan Kang Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 181. Jin Yuan Kang Bovine Blood Products Product Portfolio Table 182. Jin Yuan Kang Recent Development Table 183. Thermo Fisher Company Information Table 184. Thermo Fisher Business Overview Table 185. Thermo Fisher Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 186. Thermo Fisher Bovine Blood Products Product Portfolio Table 187. Thermo Fisher Recent Development Table 188. Zhejiang Tianhang Biotechnology Company Information Table 189. Zhejiang Tianhang Biotechnology Business Overview Table 190. Zhejiang Tianhang Biotechnology Bovine Blood Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 191. Zhejiang Tianhang Biotechnology Bovine Blood Products Product Portfolio Table 192. Zhejiang Tianhang Biotechnology Recent Development Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Bovine Blood Products Distributors List Table 196. Bovine Blood Products Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Bovine Blood Products Product Image Figure 2. Global Bovine Blood Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bovine Blood Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Bovine Blood Products Sales (2021-2032) & (K Units) Figure 5. Global Bovine Blood Products Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Bovine Blood Products Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Bovine / Cow Image Figure 9. Fetal Bovine Image Figure 10. Others Image Figure 11. Global Bovine Blood Products Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Bovine Blood Products Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Bovine Blood Products Sales Market Share by Type (2021-2032) Figure 14. Global Bovine Blood Products Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Bovine Blood Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Bovine Blood Products Revenue Market Share by Type (2021-2032) Figure 17. Scientific Research Image Figure 18. Industrial Production Image Figure 19. Global Bovine Blood Products Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Bovine Blood Products Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Bovine Blood Products Sales Market Share by Application (2021-2032) Figure 22. Global Bovine Blood Products Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Bovine Blood Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Bovine Blood Products Revenue Market Share by Application (2021-2032) Figure 25. North America Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Bovine Blood Products Sales Market Share by Country (2021-2032) Figure 27. U.S. Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Bovine Blood Products Sales Market Share by Country (2021-2032) Figure 32. Germany Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Bovine Blood Products Sales Market Share by Country (2021-2032) Figure 39. China Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Bovine Blood Products Sales Market Share by Country (2021-2032) Figure 47. Brazil Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Bovine Blood Products Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Bovine Blood Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Bovine Blood Products Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Bovine Blood Products Revenue (2021-2032) & (US$ Million) Figure 58. North America Bovine Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Bovine Blood Products Revenue (2021-2032) & (US$ Million) Figure 60. Europe Bovine Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Bovine Blood Products Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Bovine Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Bovine Blood Products Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Bovine Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Bovine Blood Products Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Bovine Blood Products Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Bovine / Cow
  • Fetal Bovine
  • Others
Applications
  • Scientific Research
  • Industrial Production
Companies covered
  • Animal Technologies
  • Bio Nutrientes Brasil
  • Biological Industries
  • Biowest
  • Bovogen
  • Cytiva
  • ExCell Bio
  • Gemini
  • Internegocios
  • Moregate BioTech
  • NorthBio
  • PAN-Biotech
  • Peak Serum
  • R&D Systems
  • RMBIO
  • Serana
  • Seroxlab
  • Tissue Culture Biologicals
  • VWR
  • WISENT
  • Corning
  • Lanzhou Minhai
  • Merck
  • Jin Yuan Kang
  • Thermo Fisher
  • Zhejiang Tianhang Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bovine Blood Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bovine Blood Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bovine Blood Products Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bovine Blood Products Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bovine Blood Products Market Dynamics
  1. 2.1 Bovine Blood Products Industry Trends
  2. 2.2 Bovine Blood Products Industry Drivers
  3. 2.3 Bovine Blood Products Industry Opportunities and Challenges
  4. 2.4 Bovine Blood Products Industry Restraints
3 Bovine Blood Products Market by Manufacturers
  1. 3.1 Global Bovine Blood Products Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bovine Blood Products Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bovine Blood Products Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bovine Blood Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bovine Blood Products Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bovine Blood Products Manufacturers, Product Type & Application
  7. 3.7 Global Bovine Blood Products Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bovine Blood Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bovine Blood Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bovine Blood Products Tier 1, Tier 2, and Tier 3
4 Bovine Blood Products Market by Type
  1. 4.1 Bovine Blood Products Type Introduction
  2. 4.1.1 Bovine / Cow
  3. 4.1.2 Fetal Bovine
  4. 4.1.3 Others
  5. 4.2 Global Bovine Blood Products Sales by Type
  6. 4.2.1 Global Bovine Blood Products Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bovine Blood Products Sales by Type (2021-2032)
  8. 4.2.3 Global Bovine Blood Products Sales Market Share by Type (2021-2032)
  9. 4.3 Global Bovine Blood Products Revenue by Type
  10. 4.3.1 Global Bovine Blood Products Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Bovine Blood Products Revenue by Type (2021-2032)
  12. 4.3.3 Global Bovine Blood Products Revenue Market Share by Type (2021-2032)
5 Bovine Blood Products Market by Application
  1. 5.1 Bovine Blood Products Application Introduction
  2. 5.1.1 Scientific Research
  3. 5.1.2 Industrial Production
  4. 5.2 Global Bovine Blood Products Sales by Application
  5. 5.2.1 Global Bovine Blood Products Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Bovine Blood Products Sales by Application (2021-2032)
  7. 5.2.3 Global Bovine Blood Products Sales Market Share by Application (2021-2032)
  8. 5.3 Global Bovine Blood Products Revenue by Application
  9. 5.3.1 Global Bovine Blood Products Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Bovine Blood Products Revenue by Application (2021-2032)
  11. 5.3.3 Global Bovine Blood Products Revenue Market Share by Application (2021-2032)
6 Global Bovine Blood Products Sales by Region
  1. 6.1 Global Bovine Blood Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bovine Blood Products Sales by Region (2021-2032)
  3. 6.2.1 Global Bovine Blood Products Sales by Region (2021-2026)
  4. 6.2.2 Global Bovine Blood Products Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bovine Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bovine Blood Products Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bovine Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bovine Blood Products Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bovine Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bovine Blood Products Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bovine Blood Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bovine Blood Products Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bovine Blood Products Revenue by Region
  1. 7.1 Global Bovine Blood Products Revenue by Region
  2. 7.1.1 Global Bovine Blood Products Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bovine Blood Products Revenue by Region (2021-2026)
  4. 7.1.3 Global Bovine Blood Products Revenue by Region (2027-2032)
  5. 7.1.4 Global Bovine Blood Products Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bovine Blood Products Revenue (2021-2032)
  8. 7.2.2 North America Bovine Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bovine Blood Products Revenue (2021-2032)
  11. 7.3.2 Europe Bovine Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bovine Blood Products Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bovine Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bovine Blood Products Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bovine Blood Products Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Animal Technologies
  2. 8.1.1 Animal Technologies Company Information
  3. 8.1.2 Animal Technologies Business Overview
  4. 8.1.3 Animal Technologies Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Animal Technologies Bovine Blood Products Product Portfolio
  6. 8.1.5 Animal Technologies Recent Developments
  7. 8.2 Bio Nutrientes Brasil
  8. 8.2.1 Bio Nutrientes Brasil Company Information
  9. 8.2.2 Bio Nutrientes Brasil Business Overview
  10. 8.2.3 Bio Nutrientes Brasil Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bio Nutrientes Brasil Bovine Blood Products Product Portfolio
  12. 8.2.5 Bio Nutrientes Brasil Recent Developments
  13. 8.3 Biological Industries
  14. 8.3.1 Biological Industries Company Information
  15. 8.3.2 Biological Industries Business Overview
  16. 8.3.3 Biological Industries Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biological Industries Bovine Blood Products Product Portfolio
  18. 8.3.5 Biological Industries Recent Developments
  19. 8.4 Biowest
  20. 8.4.1 Biowest Company Information
  21. 8.4.2 Biowest Business Overview
  22. 8.4.3 Biowest Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biowest Bovine Blood Products Product Portfolio
  24. 8.4.5 Biowest Recent Developments
  25. 8.5 Bovogen
  26. 8.5.1 Bovogen Company Information
  27. 8.5.2 Bovogen Business Overview
  28. 8.5.3 Bovogen Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bovogen Bovine Blood Products Product Portfolio
  30. 8.5.5 Bovogen Recent Developments
  31. 8.6 Cytiva
  32. 8.6.1 Cytiva Company Information
  33. 8.6.2 Cytiva Business Overview
  34. 8.6.3 Cytiva Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cytiva Bovine Blood Products Product Portfolio
  36. 8.6.5 Cytiva Recent Developments
  37. 8.7 ExCell Bio
  38. 8.7.1 ExCell Bio Company Information
  39. 8.7.2 ExCell Bio Business Overview
  40. 8.7.3 ExCell Bio Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ExCell Bio Bovine Blood Products Product Portfolio
  42. 8.7.5 ExCell Bio Recent Developments
  43. 8.8 Gemini
  44. 8.8.1 Gemini Company Information
  45. 8.8.2 Gemini Business Overview
  46. 8.8.3 Gemini Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Gemini Bovine Blood Products Product Portfolio
  48. 8.8.5 Gemini Recent Developments
  49. 8.9 Internegocios
  50. 8.9.1 Internegocios Company Information
  51. 8.9.2 Internegocios Business Overview
  52. 8.9.3 Internegocios Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Internegocios Bovine Blood Products Product Portfolio
  54. 8.9.5 Internegocios Recent Developments
  55. 8.10 Moregate BioTech
  56. 8.10.1 Moregate BioTech Company Information
  57. 8.10.2 Moregate BioTech Business Overview
  58. 8.10.3 Moregate BioTech Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Moregate BioTech Bovine Blood Products Product Portfolio
  60. 8.10.5 Moregate BioTech Recent Developments
  61. 8.11 NorthBio
  62. 8.11.1 NorthBio Company Information
  63. 8.11.2 NorthBio Business Overview
  64. 8.11.3 NorthBio Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NorthBio Bovine Blood Products Product Portfolio
  66. 8.11.5 NorthBio Recent Developments
  67. 8.12 PAN-Biotech
  68. 8.12.1 PAN-Biotech Company Information
  69. 8.12.2 PAN-Biotech Business Overview
  70. 8.12.3 PAN-Biotech Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 PAN-Biotech Bovine Blood Products Product Portfolio
  72. 8.12.5 PAN-Biotech Recent Developments
  73. 8.13 Peak Serum
  74. 8.13.1 Peak Serum Company Information
  75. 8.13.2 Peak Serum Business Overview
  76. 8.13.3 Peak Serum Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Peak Serum Bovine Blood Products Product Portfolio
  78. 8.13.5 Peak Serum Recent Developments
  79. 8.14 R&D Systems
  80. 8.14.1 R&D Systems Company Information
  81. 8.14.2 R&D Systems Business Overview
  82. 8.14.3 R&D Systems Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 R&D Systems Bovine Blood Products Product Portfolio
  84. 8.14.5 R&D Systems Recent Developments
  85. 8.15 RMBIO
  86. 8.15.1 RMBIO Company Information
  87. 8.15.2 RMBIO Business Overview
  88. 8.15.3 RMBIO Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 RMBIO Bovine Blood Products Product Portfolio
  90. 8.15.5 RMBIO Recent Developments
  91. 8.16 Serana
  92. 8.16.1 Serana Company Information
  93. 8.16.2 Serana Business Overview
  94. 8.16.3 Serana Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Serana Bovine Blood Products Product Portfolio
  96. 8.16.5 Serana Recent Developments
  97. 8.17 Seroxlab
  98. 8.17.1 Seroxlab Company Information
  99. 8.17.2 Seroxlab Business Overview
  100. 8.17.3 Seroxlab Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Seroxlab Bovine Blood Products Product Portfolio
  102. 8.17.5 Seroxlab Recent Developments
  103. 8.18 Tissue Culture Biologicals
  104. 8.18.1 Tissue Culture Biologicals Company Information
  105. 8.18.2 Tissue Culture Biologicals Business Overview
  106. 8.18.3 Tissue Culture Biologicals Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Tissue Culture Biologicals Bovine Blood Products Product Portfolio
  108. 8.18.5 Tissue Culture Biologicals Recent Developments
  109. 8.19 VWR
  110. 8.19.1 VWR Company Information
  111. 8.19.2 VWR Business Overview
  112. 8.19.3 VWR Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 VWR Bovine Blood Products Product Portfolio
  114. 8.19.5 VWR Recent Developments
  115. 8.20 WISENT
  116. 8.20.1 WISENT Company Information
  117. 8.20.2 WISENT Business Overview
  118. 8.20.3 WISENT Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 WISENT Bovine Blood Products Product Portfolio
  120. 8.20.5 WISENT Recent Developments
  121. 8.21 Corning
  122. 8.21.1 Corning Company Information
  123. 8.21.2 Corning Business Overview
  124. 8.21.3 Corning Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Corning Bovine Blood Products Product Portfolio
  126. 8.21.5 Corning Recent Developments
  127. 8.22 Lanzhou Minhai
  128. 8.22.1 Lanzhou Minhai Company Information
  129. 8.22.2 Lanzhou Minhai Business Overview
  130. 8.22.3 Lanzhou Minhai Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Lanzhou Minhai Bovine Blood Products Product Portfolio
  132. 8.22.5 Lanzhou Minhai Recent Developments
  133. 8.23 Merck
  134. 8.23.1 Merck Company Information
  135. 8.23.2 Merck Business Overview
  136. 8.23.3 Merck Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Merck Bovine Blood Products Product Portfolio
  138. 8.23.5 Merck Recent Developments
  139. 8.24 Jin Yuan Kang
  140. 8.24.1 Jin Yuan Kang Company Information
  141. 8.24.2 Jin Yuan Kang Business Overview
  142. 8.24.3 Jin Yuan Kang Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Jin Yuan Kang Bovine Blood Products Product Portfolio
  144. 8.24.5 Jin Yuan Kang Recent Developments
  145. 8.25 Thermo Fisher
  146. 8.25.1 Thermo Fisher Company Information
  147. 8.25.2 Thermo Fisher Business Overview
  148. 8.25.3 Thermo Fisher Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Thermo Fisher Bovine Blood Products Product Portfolio
  150. 8.25.5 Thermo Fisher Recent Developments
  151. 8.26 Zhejiang Tianhang Biotechnology
  152. 8.26.1 Zhejiang Tianhang Biotechnology Company Information
  153. 8.26.2 Zhejiang Tianhang Biotechnology Business Overview
  154. 8.26.3 Zhejiang Tianhang Biotechnology Bovine Blood Products Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Zhejiang Tianhang Biotechnology Bovine Blood Products Product Portfolio
  156. 8.26.5 Zhejiang Tianhang Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bovine Blood Products Value Chain Analysis
  2. 9.1.1 Bovine Blood Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bovine Blood Products Production Mode & Process
  6. 9.2 Bovine Blood Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bovine Blood Products Distributors
  9. 9.2.3 Bovine Blood Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.